208 related articles for article (PubMed ID: 29698804)
21. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
[TBL] [Abstract][Full Text] [Related]
22. Mutations in NOTCH2 in families with Hajdu-Cheney syndrome.
Majewski J; Schwartzentruber JA; Caqueret A; Patry L; Marcadier J; Fryns JP; Boycott KM; Ste-Marie LG; McKiernan FE; Marik I; Van Esch H; ; Michaud JL; Samuels ME
Hum Mutat; 2011 Oct; 32(10):1114-7. PubMed ID: 21681853
[TBL] [Abstract][Full Text] [Related]
23. A very rare cause of acro-osteolysis: Hajdu-Cheney syndrome.
Deprouw C; Feydy A; Giraudet Le Quintrec JS; Ruiz B; Kahan A; Allanore Y
Joint Bone Spine; 2015 Dec; 82(6):455-9. PubMed ID: 26184537
[TBL] [Abstract][Full Text] [Related]
24. A mutation in NOTCH2 gene in a Chinese patient with Hajdu-Cheney syndrome.
Gu JM; Hu YQ; Zhang H; Wang C; Hu WW; Yue H; Liu YJ; Zhang ZL
Joint Bone Spine; 2013 Oct; 80(5):548-9. PubMed ID: 23566664
[No Abstract] [Full Text] [Related]
25. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
26. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis.
Isidor B; Lindenbaum P; Pichon O; Bézieau S; Dina C; Jacquemont S; Martin-Coignard D; Thauvin-Robinet C; Le Merrer M; Mandel JL; David A; Faivre L; Cormier-Daire V; Redon R; Le Caignec C
Nat Genet; 2011 Mar; 43(4):306-8. PubMed ID: 21378989
[TBL] [Abstract][Full Text] [Related]
27. End-Stage Renal Disease in an Infant With Hajdu-Cheney Syndrome.
Battelino N; Writzl K; Bratanič N; Irving MD; Novljan G
Ther Apher Dial; 2016 Jun; 20(3):318-21. PubMed ID: 27312922
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
29. Novel phenotypic feature in a patient with a recurrent NOTCH2 nonsense mutation.
Tan EC; Lai AHM; Brett MSY
Am J Med Genet A; 2022 Jul; 188(7):2135-2138. PubMed ID: 35289498
[TBL] [Abstract][Full Text] [Related]
30. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
31. A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatment.
Efstathiadou ZA; Kostoulas C; Polyzos SA; Adamidou F; Georgiou I; Kita M
Endocrine; 2021 Jan; 71(1):208-215. PubMed ID: 32772338
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.
Pittaway JFH; Harrison C; Rhee Y; Holder-Espinasse M; Fryer AE; Cundy T; Drake WM; Irving MD
Orphanet J Rare Dis; 2018 Apr; 13(1):47. PubMed ID: 29618366
[TBL] [Abstract][Full Text] [Related]
33. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
34. NOTCH2 related disorders: Description and review of the fetal presentation.
Deb W; Joubert M; Cogné B; Vincent M; Ghesh L; Bézieau S; Le Vaillant C; Beneteau C
Eur J Med Genet; 2023 Jul; 66(7):104769. PubMed ID: 37121269
[TBL] [Abstract][Full Text] [Related]
35. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
36. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
[TBL] [Abstract][Full Text] [Related]
37. Hajdu-Cheney syndrome associated with serpentine fibulae and polycystic kidney disease.
Currarino G
Pediatr Radiol; 2009 Jan; 39(1):47-52. PubMed ID: 18815778
[TBL] [Abstract][Full Text] [Related]
38. Hajdu-Cheney syndrome: phenotypical progression with de-novo NOTCH2 mutation.
Descartes M; Rojnueangnit K; Cole L; Sutton A; Morgan SL; Patry L; Samuels ME
Clin Dysmorphol; 2014 Jul; 23(3):88-94. PubMed ID: 24608068
[No Abstract] [Full Text] [Related]
39. Orofacial characteristics in a child with Hajdu-Cheney syndrome.
Saji S; Devi K P; Morankar R; Tewari N; Mathur VP; Bansal K
Spec Care Dentist; 2024; 44(2):428-433. PubMed ID: 37227705
[TBL] [Abstract][Full Text] [Related]
40. Nursing Care Plan for Patients with Hajdu-Cheney Syndrome.
Cortés-Martín J; Díaz-Rodríguez L; Piqueras-Sola B; Sánchez-García JC; Menor-Rodríguez MJ; Rodríguez-Blanque R
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
